20 (AIDX) Cost of Revenue (2025 - 2026)
20's (AIDX) quarterly Cost of Revenue came in at $290491.0 in Q1 2026, down 25.14% YoY from $388025.0 in Q1 2025, and down 25.14% on a QoQ basis from $388025.0 in Q1 2025.
20 (AIDX) Cost of Revenue (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Cost of Revenue data on file, last reported at $290491.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | 20 | 5.50 Mn | 957,128.12 | 304,727.00 | 425,844.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 290,491.00 |
| Mar 31, 2026 | 290,491.00 |
| Mar 31, 2025 | 388,025.00 |
| Mar 31, 2025 | 388,025.00 |